Skip to content

Tri-Ad™ 900SFC226Recalls & reported problems

Medtronic, Inc. · BAND 900SFC226 TRI-AD2.0 ADAMS TRICUSPID · Class 2 · Implant

All models of Tri-Ad (12)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
11
Deaths reported
1
Injuries reported
10
Recalls naming it
0

Summary

The FDA's MAUDE database contains 11 adverse event reports that list this exact device (DI 00763000102302), received between Dec 5, 2019 and Jan 15, 2026 — classified as 1 death, 10 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (6 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information6
  • Adverse Event Without Identified Device or Use Problem4
  • Patient Device Interaction Problem3
  • Intravalvular regurgitation1

Patient problems

  • Insufficient Information4
  • Non specific EKG/ECG Changes2
  • Tricuspid Valve Insufficiency/ Regurgitation2
  • Cardiomyopathy1
  • Hemorrhage/Blood Loss/Bleeding1
  • No Information1
  • Stroke/CVA1
  • Valvular Insufficiency/ Regurgitation1

Recent adverse event reports

The 11 most recent of 11 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 15, 2026Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT DURING THE IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN PROD UCT. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 24078088 ↗
  • InjuryMay 19, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

    IT WAS REPORTED THAT ON THE SAME DAY AS THE IMPLANT DATE OF THIS TRI-AD 2.0 TRICUSPID BAND, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER WAS REPORTED AS CARDIOMYOPATHY. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Cardiomyopathy

    MAUDE report 22046576 ↗
  • InjuryMar 19, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

    ADDITIONAL INFORMATION WAS RECEIVED THAT THE EVENT WAS FELT TO BE CARDIOEMBOLIC IN THE SETTING OF ATRIAL FIBRILLATION AND NOT RELATED TO THE VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Stroke/CVA

    MAUDE report 21644568 ↗
  • InjuryMar 14, 2024Patient Device Interaction Problem; Patient Device Interaction Problem

    MEDTRONIC RECEIVED INFORMATION THAT 5 DAYS POST IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS REPORTED THAT THE PATIENT HAD ATRIO-VENTRICULAR BLOCK (AV BLOCK) AND PREMATURE SUPRAVENTRICULAR COMPLEXES. ANTICOAGULATION MEDICATION FOR INTERNATIONAL NORMALIZED RATIO (INR) STABILIZATION AND ASPIRIN WERE GIVEN. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Non specific EKG/ECG Changes

    MAUDE report 18908851 ↗
  • InjuryFeb 15, 2024Insufficient Device Problem Information; Intravalvular regurgitation; Insufficient Device Problem Information; Intravalvular regurgitation

    ADDITIONAL INFORMATION WAS RECEIVED THAT THE REASON FOR REPLACEMENT WAS SEVERE TRICUSPID REGURGITATION (TR). ADDITIONALLY A RIGHT THIGH AVASCULAR HEMATOMA WAS NOTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information; Tricuspid Valve Insufficiency/ Regurgitation

    MAUDE report 18709449 ↗
  • DeathAug 31, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION FROM A FAMILY MEMBER THAT DURING THE IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, THE PATIENT DIED. IT WAS ALSO REPORTED THAT, "THEY TRIED TO PUT IN A VALVE HOWEVER IT NEEDED TO BE TAKEN OUT DUE TO BLEEDING. ANOTHER VALVE WAS ATTEMPTED TO BE IMPLANTED HOWEVER THE PATIENT DID NOT SURVIVE." THE CAUSE OF DEATH WAS NOT RECEIVED. THERE WAS NO EVIDENCE TO SUGGEST THAT THE ANNULOPLASTY BAND OR ITS FUNCTION CONTRIBUTED TO THE PATIENT¿S DEATH. IT IS UNKNOWN WHETHER AN AUTOPSY WAS PERFORMED.

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 17662699 ↗
  • InjuryAug 31, 2022Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH A 29MM BIOPROSTHETIC VALVE INDICATED FOR THE MITRAL POSITION. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information

    MAUDE report 15326109 ↗
  • InjuryJul 19, 2022Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION FROM A PATIENT THAT 2 YEARS AND 11 MONTHS POST IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH A NON-MEDTRONIC VALVE. THE REASON FOR REPLACEMENT WAS REPORTED TO BE DUE TO A LEAK. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Valvular Insufficiency/ Regurgitation

    MAUDE report 15052223 ↗
  • InjuryOct 7, 2021Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 26MM TRICUSPID ANNULOPLASTY BAND, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN BIOPROSTHETIC VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information; Tricuspid Valve Insufficiency/ Regurgitation

    MAUDE report 12590455 ↗
  • InjuryJul 14, 2020Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT PROCEDURE OF A 26MM TRICUSPID ANNULOPLASTY BAND, THE BAND WAS EXPLANTED AND REPLACED WITH A 29 MM BIOPROSTHETIC MITRAL VALVE. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: No Information

    MAUDE report 10270961 ↗
  • InjuryDec 5, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT 4 DAYS POST IMPLANT OF THIS MITRAL BIOPROSTHETIC VALVE AND TRICUSPID ANNULOPLASTY BAND, A PERMANENT PACEMAKER WAS IMPLANTED DUE TO ATRIO-VENTRICULAR (AV) BLOCK. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Non specific EKG/ECG Changes

    MAUDE report 9416350 ↗

Other RING, ANNULOPLASTY devices

All RING, ANNULOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page